These technologies have also been employed to investigate the spatiotemporal relationship between synaptic and cognitive impairment and the accumulation of beta-peptide (Aβ) and phosphorylated tau (p-tau), two pathological hallmarks of AD. This evidence concerns the gene MAPT and Alzheimer disease.